• Explore /
  • Poster
  • / Association of neutrophil-lymphocyte ratio (NLR) with clinical outcomes in patients (pts) with recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) treated with combination of cetuximab and nivolumab (C+N).

Association of neutrophil-lymphocyte ratio (NLR) with clinical outcomes in patients (pts) with recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) treated with combination of cetuximab and nivolumab (C+N).

Abstract Poster

Authors

null

Robin Park

Moffitt Cancer Center, Tampa, FL

Robin Park , Fahad Rind , Tyler Kristoff , Jiannong Li , Robbert Slebos , Sowjanya Thatikonda , Ritu Chaudhary , Maria Poole , David Kaldas , Joaquim Farinhas , Juan C. Hernandez-Prera , Kedar Kirtane , James William Rocco , Priyanka Bhateja , Conor Ernst Steuer , Nabil F. Saba , Marcelo Raul Bonomi , Christine H. Chung

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Head and Neck Cancer

Track

Head and Neck Cancer

Sub Track

Advanced/Metastatic Disease

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 6021)

DOI

10.1200/JCO.2023.41.16_suppl.6021

Abstract #

6021

Poster Bd #

13

Abstract Disclosures

Similar Posters

First Author: Mark Chang

First Author: Zahra Hamedi

First Author: Chris M. Black

First Author: Kevin Joseph Harrington